5-hydroxymethylomeprazole has been researched along with 1-hydroxymethylmidazolam in 1 studies
| Studies (5-hydroxymethylomeprazole) | Trials (5-hydroxymethylomeprazole) | Recent Studies (post-2010) (5-hydroxymethylomeprazole) | Studies (1-hydroxymethylmidazolam) | Trials (1-hydroxymethylmidazolam) | Recent Studies (post-2010) (1-hydroxymethylmidazolam) |
|---|---|---|---|---|---|
| 54 | 17 | 15 | 163 | 46 | 49 |
| Protein | Taxonomy | 5-hydroxymethylomeprazole (IC50) | 1-hydroxymethylmidazolam (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 10 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frerichs, VA; Haas, CE; Zaranek, C | 1 |
1 trial(s) available for 5-hydroxymethylomeprazole and 1-hydroxymethylmidazolam
| Article | Year |
|---|---|
Analysis of omeprazole, midazolam and hydroxy-metabolites in plasma using liquid chromatography coupled to tandem mass spectrometry.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aryl Hydrocarbon Hydroxylases; Calibration; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C19; Humans; Injections, Intravenous; Mass Spectrometry; Midazolam; Mixed Function Oxygenases; Omeprazole; Reproducibility of Results; Time Factors | 2005 |